Pridopidine Protects ALS Patient-Derived Neural Progenitor Cells via Sigma-1 Receptor ActivationMay Meltzer(Ben-Gurion University of the Negev), Rachel G. Lichtenstein(Ben-Gurion University of the Negev)International Journal of Molecular SciencesApril 14, 202610.3390/ijms27083489Cited by 0SaveCiteExport RISWatch citationsRelated PapersTerminal α1,2-fucosylation of glycosphingolipids by FUT1 is a key regulator in early cell-fate decisions|EMBO Reports|2024|3A Nanobody as a Potent Angiogenesis Inhibitor That Targets the Orphan Receptor Tie1|Research Square|2022|0